Q9NQ11 (AT132_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 116.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Probable cation-transporting ATPase 13A2 EC=3.6.3.- | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1180 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May play a role in intracellular cation homeostasis and the maintenance of neuronal integrity. Ref.12 |
| Catalytic activity | ATP + H2O = ADP + phosphate. |
| Subcellular location | Membrane; Multi-pass membrane protein By similarity. Lysosome Ref.11 Ref.12. |
| Tissue specificity | Expressed in brain; protein levels are markedly increased in brain from subjects with Parkinson disease and subjects with dementia with Lewy bodies. Detected in pyramidal neurons located throughout the cingulate cortex (at protein level). In the substantia nigra, it is found in neuromelanin-positive dopaminergic neurons (at protein level). Ref.12 |
| Involvement in disease | Kufor-Rakeb syndrome (KRS) [MIM:606693]: A rare form of autosomal recessive juvenile or early-onset, levodopa-responsive parkinsonism. In addition to typical parkinsonian signs, clinical manifestations of Kufor-Rakeb syndrome include behavioral problems, facial tremor, pyramidal tract dysfunction, supranuclear gaze palsy, and dementia. |
| Sequence similarities | Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type V subfamily. [View classification] |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Lysosome Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Disease mutation Parkinsonism |
| Domain | Transmembrane Transmembrane helix |
| Ligand | ATP-binding Magnesium Metal-binding Nucleotide-binding |
| Molecular function | Hydrolase |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | ATP catabolic process Inferred from electronic annotation. Source: GOC |
| Cellular_component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW lysosomeInferred from direct assay Ref.11. Source: UniProtKB |
| Molecular_function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW cation-transporting ATPase activityInferred from electronic annotation. Source: InterPro metal ion bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| AAK1 | Q2M2I8 | 2 | EBI-6308763,EBI-1383433 | |
| BNIP3L | O60238 | 2 | EBI-6308763,EBI-849893 | |
| GAK | O14976 | 2 | EBI-6308763,EBI-714707 | |
| HDAC6 | Q9UBN7 | 2 | EBI-6308763,EBI-301697 | |
| HSPA8 | P11142 | 2 | EBI-6308763,EBI-351896 | |
| SYT11 | Q9BT88 | 2 | EBI-6308763,EBI-751770 | |
| YIF1A | O95070 | 2 | EBI-6308763,EBI-2799703 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform A (identifier: Q9NQ11-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform B (identifier: Q9NQ11-2) The sequence of this isoform differs from the canonical sequence as follows: 155-159: Missing. 805-843: Missing. 1079-1180: VPFLVALALL...WPPLPAGPLR → ERARPVPPRL...PPPWGSVDYC | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q9NQ11-3) The sequence of this isoform differs from the canonical sequence as follows: 155-159: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1180 | 1180 | Probable cation-transporting ATPase 13A2 | PRO_0000046423 | |||||
Regions | |||||||||
| Topological domain | 1 – 12 | 12 | Cytoplasmic Potential | ||||||
| Transmembrane | 13 – 34 | 22 | Helical; Potential | ||||||
| Topological domain | 35 – 45 | 11 | Extracellular Potential | ||||||
| Transmembrane | 46 – 66 | 21 | Helical; Potential | ||||||
| Topological domain | 67 – 230 | 164 | Cytoplasmic Potential | ||||||
| Transmembrane | 231 – 253 | 23 | Helical; Potential | ||||||
| Topological domain | 254 – 256 | 3 | Extracellular Potential | ||||||
| Transmembrane | 257 – 276 | 20 | Helical; Potential | ||||||
| Topological domain | 277 – 425 | 149 | Cytoplasmic Potential | ||||||
| Transmembrane | 426 – 445 | 20 | Helical; Potential | ||||||
| Topological domain | 446 – 459 | 14 | Extracellular Potential | ||||||
| Transmembrane | 460 – 480 | 21 | Helical; Potential | ||||||
| Topological domain | 481 – 932 | 452 | Cytoplasmic Potential | ||||||
| Transmembrane | 933 – 952 | 20 | Helical; Potential | ||||||
| Topological domain | 953 – 963 | 11 | Extracellular Potential | ||||||
| Transmembrane | 964 – 981 | 18 | Helical; Potential | ||||||
| Topological domain | 982 – 997 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 998 – 1018 | 21 | Helical; Potential | ||||||
| Topological domain | 1019 – 1046 | 28 | Extracellular Potential | ||||||
| Transmembrane | 1047 – 1066 | 20 | Helical; Potential | ||||||
| Topological domain | 1067 – 1079 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 1080 – 1097 | 18 | Helical; Potential | ||||||
| Topological domain | 1098 – 1113 | 16 | Extracellular Potential | ||||||
| Transmembrane | 1114 – 1134 | 21 | Helical; Potential | ||||||
| Topological domain | 1135 – 1180 | 46 | Cytoplasmic Potential | ||||||
Sites | |||||||||
| Active site | 513 | 1 | 4-aspartylphosphate intermediate By similarity | ||||||
| Metal binding | 878 | 1 | Magnesium By similarity | ||||||
| Metal binding | 882 | 1 | Magnesium By similarity | ||||||
Natural variations | |||||||||
| Alternative sequence | 155 – 159 | 5 | Missing in isoform B and isoform 3. | VSP_007310 | |||||
| Alternative sequence | 805 – 843 | 39 | Missing in isoform B. | VSP_007311 | |||||
| Alternative sequence | 1079 – 1180 | 102 | VPFLV…AGPLR → ERARPVPPRLPAPPPAQAGL QEALQAAGTRAGRAALAAAA RRPPEVVQAHGHPRHWNSLP LSHQLDPSPATPPPPPPTSL RLATVYTPPPRPPPPWGSVD YC in isoform B. | VSP_007312 | |||||
| Natural variant | 12 | 1 | T → M. Ref.13 Corresponds to variant rs151117874 [ dbSNP | Ensembl ]. | VAR_058451 | |||||
| Natural variant | 49 | 1 | G → S. Ref.16 Corresponds to variant rs56379718 [ dbSNP | Ensembl ]. | VAR_058452 | |||||
| Natural variant | 182 | 1 | F → L in KRS. Ref.14 | VAR_066019 | |||||
| Natural variant | 294 | 1 | R → Q. Ref.16 Corresponds to variant rs56367069 [ dbSNP | Ensembl ]. | VAR_058453 | |||||
| Natural variant | 389 | 1 | P → L. Ref.16 Corresponds to variant rs56275621 [ dbSNP | Ensembl ]. | VAR_058454 | |||||
| Natural variant | 504 | 1 | G → R in KRS. Ref.13 Corresponds to variant rs121918227 [ dbSNP | Ensembl ]. | VAR_058455 | |||||
| Natural variant | 533 | 1 | G → R in a patient with early onset Parkinson disease. Ref.13 | VAR_058456 | |||||
| Natural variant | 578 | 1 | V → G. Ref.16 Corresponds to variant rs56186751 [ dbSNP | Ensembl ]. | VAR_058457 | |||||
| Natural variant | 746 | 1 | A → T. Ref.15 Corresponds to variant rs147277743 [ dbSNP | Ensembl ]. | VAR_058458 | |||||
| Natural variant | 762 | 1 | R → W. Ref.16 Corresponds to variant rs55635527 [ dbSNP | Ensembl ]. | VAR_058459 | |||||
| Natural variant | 776 | 1 | V → I. Ref.16 Corresponds to variant rs56170027 [ dbSNP | Ensembl ]. | VAR_058460 | |||||
| Natural variant | 877 | 1 | G → R in KRS; found in two affected brothers also carrying C-481 in FBXO7. Ref.17 | VAR_066020 | |||||
| Natural variant | 946 | 1 | I → F. Ref.16 Corresponds to variant rs55708915 [ dbSNP | Ensembl ]. | VAR_058461 | |||||
| Natural variant | 1059 | 1 | L → R in KRS; the mutant protein is retained in the endoplasmic reticulum. Ref.11 | VAR_066021 | |||||
Experimental info | |||||||||
| Sequence conflict | 322 | 1 | Q → R in AAH30267. Ref.6 | ||||||
| Sequence conflict | 855 – 858 | 4 | APEQ → IPRA in CAA08912. Ref.8 | ||||||
| Sequence conflict | 861 | 1 | E → V in CAA08912. Ref.8 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Rhodes S., Huckle E. Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A). |
| [2] | "Homo sapiens putative ATPase (N-ATPase) mRNA." Liu J.-P., Li H. Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Thalamus. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B). Tissue: Brain and Fetus. |
| [7] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 705-1180 (ISOFORM A). Tissue: Amygdala. |
| [8] | "YAC analysis and genes identification at a site of viral integration in the 1p36.1-36.2 chromosomal site." Casciano I., Volpi E.V., De Ambrosis A., Marchi J.M., Romani M. Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 855-1180 (ISOFORM B). |
| [9] | "Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase." Ramirez A., Heimbach A., Gruendemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.-L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C. Nat. Genet. 38:1184-1191(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN KRS. |
| [10] | "Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations." Behrens M.I., Bruggemann N., Chana P., Venegas P., Kagi M., Parrao T., Orellana P., Garrido C., Rojas C.V., Hauke J., Hahnen E., Gonzalez R., Seleme N., Fernandez V., Schmidt A., Binkofski F., Kompf D., Kubisch C. Ramirez A.Mov. Disord. 25:1929-1937(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN KRS. |
| [11] | "Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism." Park J.S., Mehta P., Cooper A.A., Veivers D., Heimbach A., Stiller B., Kubisch C., Fung V.S., Krainc D., Mackay-Sim A., Sue C.M. Hum. Mutat. 32:956-964(2011) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, VARIANT KRS ARG-1059, CHARACTERIZATION OF VARIANT KRS ARG-1059. |
| [12] | "PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity." Ramonet D., Podhajska A., Stafa K., Sonnay S., Trancikova A., Tsika E., Pletnikova O., Troncoso J.C., Glauser L., Moore D.J. Hum. Mol. Genet. 21:1725-1743(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [13] | "ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease." Di Fonzo A., Chien H.F., Socal M., Giraudo S., Tassorelli C., Iliceto G., Fabbrini G., Marconi R., Fincati E., Abbruzzese G., Marini P., Squitieri F., Horstink M.W., Montagna P., Libera A.D., Stocchi F., Goldwurm S., Ferreira J.J. Bonifati V.Neurology 68:1557-1562(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT KRS ARG-504, VARIANTS MET-12 AND ARG-533. |
| [14] | "PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype." Ning Y.P., Kanai K., Tomiyama H., Li Y., Funayama M., Yoshino H., Sato S., Asahina M., Kuwabara S., Takeda A., Hattori T., Mizuno Y., Hattori N. Neurology 70:1491-1493(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT KRS LEU-182. |
| [15] | "Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore." Lin C.H., Tan E.K., Chen M.L., Tan L.C., Lim H.Q., Chen G.S., Wu R.M. Neurology 71:1727-1732(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT THR-746. |
| [16] | "ATP13A2 variability in Parkinson disease." Vilarino-Guell C., Soto A.I., Lincoln S.J., Ben Yahmed S., Kefi M., Heckman M.G., Hulihan M.M., Chai H., Diehl N.N., Amouri R., Rajput A., Mash D.C., Dickson D.W., Middleton L.T., Gibson R.A., Hentati F., Farrer M.J. Hum. Mutat. 30:406-410(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SER-49; GLN-294; LEU-389; GLY-578; TRP-762; ILE-776 AND PHE-946. |
| [17] | "Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability." Santoro L., Breedveld G.J., Manganelli F., Iodice R., Pisciotta C., Nolano M., Punzo F., Quarantelli M., Pappata S., Di Fonzo A., Oostra B.A., Bonifati V. Neurogenetics 12:33-39(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT KRS ARG-877. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AL354615 mRNA. Translation: CAB89728.1. AY461712 mRNA. Translation: AAR23423.1. AK290210 mRNA. Translation: BAF82899.1. AL049569 Genomic DNA. Translation: CAI20366.1. CH471134 Genomic DNA. Translation: EAW94827.1. BC030267 mRNA. Translation: AAH30267.1. AL833966 mRNA. Translation: CAD38813.2. AJ009947 mRNA. Translation: CAA08912.1. |
| IPI | IPI00015154. IPI00177535. IPI00915298. |
| RefSeq | NP_001135445.1. NM_001141973.1. NP_001135446.1. NM_001141974.1. NP_071372.1. NM_022089.2. |
| UniGene | Hs.128866. |
3D structure databases | |
| ProteinModelPortal | Q9NQ11. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9NQ11. 42 interactions. |
| STRING | 9606.ENSP00000327214. |
Protein family/group databases | |
| TCDB | 3.A.3.13.1. P-type ATPase (P-ATPase) superfamily. |
PTM databases | |
| PhosphoSite | Q9NQ11. |
Polymorphism databases | |
| DMDM | 14285364. |
Proteomic databases | |
| PaxDb | Q9NQ11. |
| PRIDE | Q9NQ11. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000326735; ENSP00000327214; ENSG00000159363. ENST00000452699; ENSP00000413307; ENSG00000159363. |
| GeneID | 23400. |
| KEGG | hsa:23400. |
| UCSC | uc001baa.2. human. |
Organism-specific databases | |
| CTD | 23400. |
| GeneCards | GC01M017312. |
| HGNC | HGNC:30213. ATP13A2. |
| HPA | CAB037111. |
| MIM | 606693. phenotype. 610513. gene. |
| neXtProt | NX_Q9NQ11. |
| Orphanet | 2828. Young adult-onset Parkinsonism. |
| PharmGKB | PA134897221. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0474. |
| HOGENOM | HOG000171813. |
| HOVERGEN | HBG065757. |
| InParanoid | Q9NQ11. |
| KO | K13526. |
| OMA | FRWKPLW. |
| OrthoDB | EOG4M0F0W. |
| PhylomeDB | Q9NQ11. |
Gene expression databases | |
| ArrayExpress | Q9NQ11. |
| Bgee | Q9NQ11. |
| CleanEx | HS_ATP13A2. |
| Genevestigator | Q9NQ11. |
| GermOnline | ENSG00000159363. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.70.150.10. 1 hit. 3.40.1110.10. 2 hits. 3.40.50.1000. 2 hits. |
| InterPro | IPR004014. ATPase_P-typ_cation-transptr_N. IPR006544. ATPase_P-typ_Cation_typ_V. IPR023299. ATPase_P-typ_cyto_domN. IPR018303. ATPase_P-typ_P_site. IPR008250. ATPase_P-typ_transduc_dom_A. IPR001757. Cation_transp_P_typ_ATPase. IPR023214. HAD-like_dom. [Graphical view] |
| PANTHER | PTHR24093. PTHR24093. 1 hit. |
| Pfam | PF00122. E1-E2_ATPase. 1 hit. PF12409. P5-ATPase. 1 hit. [Graphical view] |
| PRINTS | PR00119. CATATPASE. |
| SMART | SM00831. Cation_ATPase_N. 1 hit. [Graphical view] |
| SUPFAM | SSF81660. ATPase_cation_domN. 1 hit. SSF56784. HAD-like_dom. 1 hit. |
| TIGRFAMs | TIGR01494. ATPase_P-type. 2 hits. TIGR01657. P-ATPase-V. 1 hit. |
| PROSITE | PS00154. ATPASE_E1_E2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | ATP13A2. human. |
| GenomeRNAi | 23400. |
| NextBio | 45553. |
| SOURCE | Search... |
Entry information
| Entry name | AT132_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NQ11 Secondary accession number(s): O75700, Q5JXY2, Q6S9Z9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
